RxDoctor Payments Data

Vinod Panchbhavi, MD

Foot and Ankle Surgery · Galveston, TXNPI 1215016837

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $286,300 of the $389,373 with a category attached, or 73.5%. Stryker accounts for 74.3% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $94,864, 3.2 times the $29,487 reported in 2019. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$389,373in general payments, 2019–2025

Across 788 payments — averaging $494.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$289K
  • Linvatec Corporation$38K
  • Trilliant Surgical LLC.$27K
  • Encore Medical, LP$11K
  • Medshape, Inc.$10K
  • GLW, Inc$7K
  • plus $6K from 19 others
$3,250in research payments, 2019–2025

Across 2 payments — averaging $1625.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ferring International Pharmascience Center US$3K

What the payments were for

  • Royalty or licence$7,0802%
  • Consulting fees$286,30074%
  • Grants$2,5001%
  • Travel & lodging$65,19317%
  • Food & beverage$26,8737%
  • Education$1,4270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$389,373 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$52,079
Medicare patients
127
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen41$437
Gabapentin15$144

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Galveston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →